C188 is a STAT3 inhibitor that suppresses IL-6-induced STAT3 phosphorylation and nuclear translocation in HepG2 cells by targeting the peptide-binding pocket of the STAT3 SH2 domain; it exhibits potent activity in inducing apoptosis in breast cancer MB-MDA-468 cells in vitro (EC50 = 0.7 μM).